Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Colorado for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Colorado only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Colorado (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Manojkumar Bupathi (NPI 1265675433)

Field	Value
Entity Type	Individual
Organization	Manojkumar Bupathi
Address	22 W Dry Creek Cir
City	Littleton
State	CO
ZIP	80120
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	April 17, 2009

Payer Source	Total Paid
Medicare	$1.4M
Medicaid	$0

Key Findings

MANOJKUMAR BUPATHI is a Hematology & Oncology Physician in LITTLETON, CO with an NPI enumerated 2009-04-17 (~17 years ago). The provider’s Medicare footprint totals $1.4M in lifetime Medicare revenue, and there is no Medicaid billing on file, indicating an effectively single‑payer Medicare practice at the claim level.

Revenue for this provider is highly concentrated: the precomputed top 3 Medicare codes by revenue account for 76.2% of this provider's total Medicare revenue. Those three codes are J9271 ($864.3K, 63.0% of Medicare revenue), 99214 ($94.7K, 6.9%), and J0897 ($87.5K, 6.4%), so a single high-cost drug dominates the practice’s topline.

The code mix points to an oncology infusion practice focused on high-cost systemic therapy with adjacent supportive care. J9271 (pembrolizumab) is the largest revenue driver ($864.3K, 63.0%), complemented by administration/chemotherapy codes such as 96413 ($41.2K) and supportive agents J2506 ($42.8K) and J0897 (denosumab, $87.5K), which together suggest treatment of solid tumors with immunotherapy and routine supportive oncology services.

Despite the dominance of J9271 in revenue share, the provider’s national competitive standing on that drug is middle‑tier: J9271 ranks #395 of 1841 providers nationally (79th percentile; typical, unremarkable volume for this code). By contrast, office visit coding shows above‑typical national activity: 99214 (966 claims, $94.7K) ranks #12442 of 479517 providers (97th percentile; notably above typical national volume), and 99215 (359 claims, $50.6K) also ranks in the 97th percentile (notably above typical), indicating higher E/M intensity relative to peers.

Operationally the practice appears to support a high volume of on‑site monitoring and laboratory follow‑up consistent with active systemic oncology care. High claim counts and revenue for lab and draw codes — 80053 (1.9K claims, $18.6K, 1.4%) and 85025 (2.1K claims, $17.1K, 1.2%) and 36415 (2.1K claims, $16.9K, 1.2%) — all sit in the upper national percentiles (each flagged as 97th–99th percentile; typical, unremarkable volume), reflecting routine surveillance and specimen collection workflows.

Payer mix is essentially single‑payer Medicare: the dataset shows Total Medicare revenue: $1.4M and none for Medicaid, and the record explicitly has no Medicaid billing on file. This limited Medicaid exposure could shape referral patterns and network participation decisions, and it suggests the provider’s revenue and utilization analyses should be benchmarked primarily against Medicare peer cohorts.

There are mixed signals on breadth of service lines: while oncology drug administration and supportive agents drive revenue (J9271, J0897, J2506), the presence of outpatient E/M codes across new and established visits (99205, 99204, 99214, 99215) plus monthly oncology model payment M0010 ($9K, 0.7%) implies the practice combines infusion services with longitudinal office‑based management. Several visit and monitoring codes are in high national percentiles (99214 and 99215 at the 97th percentile; 99205 at the 93th percentile), suggesting both higher acuity visits and active new‑patient throughput.

Statistical standing across codes is uneven: some high‑revenue items are described as typical for national volume (J9271 is 79th percentile; typical, unremarkable volume), while key E/M codes are described as notably above typical (99214 and 99215 at the 97th percentile; notably above typical national volume). Lower‑revenue drug lines such as J9217 (73 claims, $9.6K, 0.7%) are listed with a 15th percentile description (typical, unremarkable volume), indicating that outside of pembrolizumab and a few supportive agents the provider’s use of other specialty drugs is modest.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

60 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	20,100	$40	$864.3K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	970	$100	$94.7K
J0897	Injection, denosumab, 1 mg	4,860	$20	$87.5K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	360	$140	$50.6K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	490	$90	$42.8K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	390	$110	$41.2K
Q5122	Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg	290	$80	$23K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	310	$60	$19K
80053	The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel.	1,860	$10	$18.6K
85025	A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a…	2,140	$10	$17.1K

Showing 1–10 of 60

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 60 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Colorado Distribution

Manojkumar Bupathi — 8 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Colorado

Full comparison — all codes billed, vs. state median

60 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	3	40	10,700	$40	$520.5K
J0897	34	140	2,580	$20	$68.8K
J2506	1	10	370	$90	$32.3K
Q5122	8	10	320	$90	$30.7K
J3490	25	60	50	$290	$23.1K
96413	19	140	130	$100	$19.7K
J9217	41	60	100	$130	$15.6K
74177	427	470	120	$80	$12.1K
99214	42	8,160	80	$80	$11.3K
80053	9	250	80	$10	$10K

Showing 1–10 of 60

Related Providers

Other providers that share a Tax Identification Number (TIN) with Manojkumar Bupathi, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Nauman Moazzam	CO	Hematology & Oncology Physician	$3.6M	$0
Robert Rifkin	CO	Hematology & Oncology Physician	$3.3M	$0
Ioana Hinshaw	CO	Hematology & Oncology Physician	$2.7M	$0
John Burke	CO	Hematology & Oncology Physician	$2.6M	$0
Patrick Eulitt	CO	Medical Oncology Physician	$2.4M	$0
Patrick Richard	CO	Radiation Oncology Physician	$1.9M	$0
Christopher Benton	CO	Hematology & Oncology Physician	$1.8M	$0
Paul Decarolis	CO	Hematology & Oncology Physician	$1.6M	$0
Maurice Markus	CO	Hematology & Oncology Physician	$1.6M	$0
Sujatha Nallapareddy	CO	Hematology & Oncology Physician	$1.4M	$0

Nearby Providers

Other providers in the same ZIP code as Manojkumar Bupathi, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Integrated Life Choices	CO	Developmentally Disabled Services Day Training Agency	$0	$123.6M
Caps - Mental Health And Dui Services, LLC	CO	Community/Behavioral Health Agency	$0	$6.8M
Actualize Behavior Alternatives	CO	Clinical Social Worker	$0	$6.4M
Andy M. Fine, M.d., Inc	CO	Internal Medicine Physician	$0	$3.8M
Rocky Mountain Health & Rehab, LLC	CO	Physical Therapist	$0	$3.5M
Functional Neurosurgical Ambulatory Surgery Center,llc	CO	Ambulatory Surgical Clinic/Center	$955.9K	$0
Arapahoe Surgicenter, LLC	CO	Ambulatory Surgical Clinic/Center	$452K	$353.4K
Charles Leonard	CO	Radiation Oncology Physician	$495.5K	$0
Littleton Day Surgery Center LLC	CO	Ambulatory Surgical Clinic/Center	$384.3K	$0
Marie Weeks	CO	Radiation Oncology Physician	$355.2K	$0

Manojkumar Bupathi — Billing Profile & Reimbursement Data

Sign up for Manojkumar Bupathi — Billing Profile & Reimbursement Data policy alerts

Manojkumar Bupathi — Billing Profile & Reimbursement Data

Sign up for Manojkumar Bupathi — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References